GingiCaine Gel, Chocolate Mint

Product NDC: 10129-034
11-digit product format: 101290034
Labeler code: 10129
Product ID: 10129-034_556cb4b1-8f13-33c6-e063-6294a90a6892
Type: HUMAN OTC DRUG
Nonproprietary name: GingiCaine Gel, Chocolate Mint Flavor
Dosage form: GEL
Route: DENTAL; ORAL; PERIODONTAL
Labeler: Gingi-Pak a Division of the Belport
Application: M022
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 1993-07-06
Substance: BENZOCAINE
Active strength: 200 mg/1
Pharmacologic classes: Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 27 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10129-034-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10129-034-05	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10129-034-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10129-034-05	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10129-034-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10129-034-05	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10129-034-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10129-034-05	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10129-034-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10129-034-05	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10129-034-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10129-034-05	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10129-034-01	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10129-034-05	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10129-034-01	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10129-034-05	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10129-034-01	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10129-034-05	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: GingiCaine Gel, Chocolate Mint
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
BENZOCAINE	200 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
U3RSY48JW5	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
238910	Internal RxNorm lookup
543801	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6285c4f2-c139-49a9-e053-2991aa0a2b03	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
10129-034-01	2025-01-30	GingiCaine Gel, Chocolate Mint
10129-034-01	2025-01-30	GingiCaine Gel, Chocolate Mint
10129-034-05	2025-01-30	GingiCaine Gel, Chocolate Mint
10129-034-05	2025-01-30	GingiCaine Gel, Chocolate Mint
10129-034-01	2021-09-02	GingiCaine Gel, Chocolate Mint
10129-034-01	2021-09-02	GingiCaine Gel, Chocolate Mint
10129-034-05	2021-09-02	GingiCaine Gel, Chocolate Mint
10129-034-05	2021-09-02	GingiCaine Gel, Chocolate Mint
10129-034-01	2021-07-23	GingiCaine Gel, Chocolate Mint
10129-034-01	2021-07-23	GingiCaine Gel, Chocolate Mint
10129-034-05	2021-07-23	GingiCaine Gel, Chocolate Mint
10129-034-05	2021-07-23	GingiCaine Gel, Chocolate Mint

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
10129-034-01	GingiCaine Gel, Chocolate Mint	1 in 1 BOTTLE, PLASTIC	GEL	1		2
10129-034-05	GingiCaine Gel, Chocolate Mint	6 in 1 BOTTLE, PLASTIC	GEL	6		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10129-034	GINGICAINE GEL, CHOCOLATE MINT (GINGICAINE GEL, CHOCOLATE MINT FLAVOR) GEL [GINGI-PAK A DIVISION OF THE BELPORT]	2	Current NDC, Legacy NDC, 2 package rows	20211210_6285c4f2-c139-49a9-e053-2991aa0a2b03.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 13 of 41 · 818 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Hydrogen Peroxide	HYDROGEN PEROXIDE	CVS PHARMACY, INC	3b0ad9ac-4920-45a7-b336-dfa7f8d9bdb2	2025-12-17	Warnings	Exact identifier application number: M022
Sore Throat	PHENOL	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	9128d59c-6fa9-4358-865a-802257a9bd25	2025-12-16	Warnings	Exact identifier application number: M022
S.T.37	HEXYLRESORCINOL	NUMARK BRANDS, INC	7d7acca2-aa8a-5272-e813-faab039cc798	2025-12-15	Warnings	Exact identifier application number: M022
Esunix Oral Bacteriostatic Gel	CETYLPYRIDINIUM CHLORIDE	Xiling (Zhenjiang) Medical Technology Co., Ltd.	3f4ee467-8142-8cb7-e063-6394a90aa7f7	2025-12-12	Warnings	Exact identifier application number: M022
Orajel 4X Medicated For Toothache and Gum	BENZALKONIUM CHLORIDE, BENZOCAINE, MENTHOL, ZINC CHLORIDE	Church & Dwight Co., Inc.	999851ac-925c-7d1f-e053-2a95a90a240b	2025-12-12	Warnings	Exact identifier application number: M022
Orajel 3X Medicated For Toothache and Gum	BENZOCAINE, MENTHOL, ZINC CHLORIDE	Church & Dwight Co., Inc.	99a2b061-0875-59a4-e053-2995a90ab373	2025-12-12	Warnings	Exact identifier application number: M022
Orajel Antiseptic Rinse For All Mouth Sores	HYDROGEN PEROXIDE AND MENTHOL	Church & Dwight Co., Inc.	06188d36-0d60-6ae6-e054-00144ff8d46c	2025-12-12	Warnings	Exact identifier application number: M022
Orajel 3X Medicated For All Mouth Sores	BENZOCAINE, MENTHOL, ZINC CHLORIDE	Church & Dwight Co., Inc.	99b589ac-9833-fb60-e053-2995a90a0935	2025-12-12	Warnings	Exact identifier application number: M022
Orajel 4X Medicated For Toothache and Gum, Cream	BENZALKONIUM CHLORIDE, BENZOCAINE, MENTHOL, ZINC CHLORIDE	Church & Dwight Co., Inc.	999aa7b9-bf9e-9285-e053-2a95a90a345b	2025-12-12	Warnings	Exact identifier application number: M022
Orajel 4X Medicated PM For Toothache and Gum	BENZALKONIUM CHLORIDE, BENZOCAINE, MENTHOL, ZINC CHLORIDE	Church & Dwight Co., Inc.	999cff2b-c23e-5abe-e053-2a95a90a7569	2025-12-12	Warnings	Exact identifier application number: M022
Vicks Formula 44 Cough Drops	MENTHOL	The Procter & Gamble Manufacturing Company	bb9e483e-095d-8a42-e053-2a95a90ad8d6	2025-12-12	Warnings	Exact identifier application number: M022
Benzoin Compound Tincture	BENZOIN RESIN	Humco Holding Group, Inc.	a893a232-2ea8-4e0d-8cbf-7f5040b3be2e	2025-12-11	Warnings	Exact identifier application number: M022
Listerine Original Intense Antiseptic Antigingivitis/ Antiplaque Mouthwash	EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL	Kenvue Brands LLC	456d45e8-bf6d-31c4-e063-6394a90a5c00	2025-12-10	Warnings	Exact identifier application number: M022
Oral pain relief	BENZOCAINE	ALAINA HEALTHCARE PRIVATE LIMITED	d98c1b2f-fe75-4d52-b082-1abb7628c59e	2025-12-09	Warnings	Exact identifier application number: M022
HEB Sensitive Extra Whitening Twin	SODIUM FLUORIDE	HEB	41d5ae3e-51c1-263b-e063-6394a90a3312	2025-12-08	Warnings	Exact identifier application number: M022
CankerMelts	BENZOCAINE	Quest Products, LLC	070dae82-14c2-66d2-e063-6394a90ab259	2025-12-04	Warnings	Exact identifier application number: M022
Sore Throat ReadyInCase	PHENOL	P & L Development, LLC	2fb3d17e-8ca3-4edb-8b82-4b484f42616e	2025-12-03	Warnings	Exact identifier application number: M022
Listerine Cool Mint Intense Antiseptic Antigingivitis/ Antiplaque Mouthwash	EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL	Kenvue Brands LLC	44f2b66a-26ae-1044-e063-6394a90a9ab6	2025-12-02	Warnings	Exact identifier application number: M022
Sensodyne Fresh Clean	STANNOUS FLUORIDE	Haleon US Holdings LLC	2d433ac1-3ddf-a2f4-e063-6394a90a91f8	2025-12-01	Warnings	Exact identifier application number: M022
Walgreens Saline	NASAL	WALGREEN COMPANY	147e45c8-1e71-4c06-89f1-42e9f9683366	2025-12-01	Warnings	Exact identifier application number: M022

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
U3RSY48JW5	BENZOCAINE	94-09-7	BENZOCAINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
238910	benzocaine 20 % Oral Gel	PSN	6285c4f2-c139-49a9-e053-2991aa0a2b03	2
543801	Gingicaine 20 % Oral Gel	PSN	6285c4f2-c139-49a9-e053-2991aa0a2b03	2
543801	benzocaine 0.2 MG/MG Oral Gel [Gingicaine]	SBD	6285c4f2-c139-49a9-e053-2991aa0a2b03	2
238910	benzocaine 0.2 MG/MG Oral Gel	SCD	6285c4f2-c139-49a9-e053-2991aa0a2b03	2
238910	benzocaine 20 % (180-220 MG per 1 GM) Oral Gel	SY	6285c4f2-c139-49a9-e053-2991aa0a2b03	2
543801	Gingicaine 0.2 MG/MG Oral Gel	SY	6285c4f2-c139-49a9-e053-2991aa0a2b03	2
543801	Gingicaine 20 % Oral Gel	SY	6285c4f2-c139-49a9-e053-2991aa0a2b03	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
10129-034-01	10129003401	1 GEL in 1 BOTTLE, PLASTIC (10129-034-01)	1 gel	1993-07-06	0000-00-00	No	No	Current
10129-034-05	10129003405	6 GEL in 1 BOTTLE, PLASTIC (10129-034-05)	6 gel	1993-07-06	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GingiCaine Gel, Chocolate Mint	Gingi-Pak a Division of the Belport	2026-06-29	HUMAN OTC DRUG LABEL	3